What does IQVIA data show about Xolair’s age distribution?
“IQVIA xolair age distribution” typically refers to how patients receiving Xolair (omalizumab) are distributed across age groups in IQVIA’s claims or prescribing datasets. That distribution depends on the exact IQVIA view (market, geography, year range) and on which patient cohort you pull (all treated patients vs. new starts, asthma vs. chronic spontaneous urticaria, etc.). The provided information doesn’t include any specific IQVIA age-by-age results, so the exact percentages by age bracket aren’t available here.
Which Xolair populations usually drive the age pattern (asthma vs. chronic urticaria)?
Age distribution can differ depending on the indication:
- For asthma, use is often concentrated in adults but can include adolescents and some children depending on eligibility and local prescribing patterns.
- For chronic spontaneous urticaria, prescribing tends to skew toward adults, with fewer pediatric patients in many real‑world datasets.
If your query is about “all Xolair users” regardless of indication, the combined age mix will reflect the relative share of those indications in the dataset and the timeframe.
What data cuts change the age distribution most?
Users commonly see different age curves when the dataset is filtered by:
- New prescriptions/initiations vs. all treated patients
- Specific brands/forms/indications (IQVIA sometimes distinguishes product lines or therapeutic areas)
- Time window (e.g., recent year vs. multi‑year trend)
- Geography and payer mix (commercial vs. Medicare/Medicaid)
- Settings (claims prescribing vs. patient services datasets)
How can you pull the exact IQVIA age distribution you’re looking for?
To get an actual age distribution table from IQVIA, you’d need the same inputs the report was built with, such as:
- Year(s) and geography
- Source (e.g., claims, pharmacy, patient services)
- Indication(s) included
- Cohort definition (all patients on therapy vs. new starts)
- Age banding scheme (e.g., 0–17, 18–24, 25–34, etc.)
If you paste the IQVIA output (or the age bins and counts/percentages you see), I can help you interpret it and summarize the main age concentration and how it changes across your selected period.
If you meant “what are Xolair’s age demographics clinically?”
If your intent is clinical rather than IQVIA-specific, the demographics depend on indication and local approved/prescribing populations, and can’t be answered precisely from the phrase alone.
Quick clarification so I can answer with numbers
What exactly do you want:
1) IQVIA age distribution for which indication (asthma, chronic spontaneous urticaria, or both)?
2) Which geography and which year range?
3) Are you looking for all treated patients or new starts?
Share those details (or the IQVIA table/screenshot text), and I’ll turn it into a clear age-distribution summary.